Toward operative in vivo fluorescence imaging of the c‐<scp>M</scp>et proto‐oncogene for personalization of therapy in ovarian cancer

Abstract

Our results suggest that intraoperative optical imaging could provide a new paradigm for selecting cancer patients for appropriate targeted therapies, particularly after initial chemotherapy.